Goldman Sachs Leads $62M Series D Round In Chinese CRO Firm Fountain Medical
October 26, 2019 — 17:53 CST
This Data Is Locked!
This area is available only to Subscribers.
Fountain Medical, a Chinese clinical-stage contract research organization (CRO) offering one-stop services to pharmaceutical and medical device companies, has raised US$62 million in a series... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals